nodes	percent_of_prediction	percent_of_DWPC	metapath
Clonazepam—CYP3A4—Everolimus—kidney cancer	0.0857	0.237	CbGbCtD
Clonazepam—ALB—Erlotinib—kidney cancer	0.0692	0.191	CbGbCtD
Clonazepam—CYP3A4—Temsirolimus—kidney cancer	0.0579	0.16	CbGbCtD
Clonazepam—NAT2—urine—kidney cancer	0.0425	0.482	CbGeAlD
Clonazepam—CYP3A4—Pazopanib—kidney cancer	0.0304	0.084	CbGbCtD
Clonazepam—CYP3A4—Erlotinib—kidney cancer	0.0217	0.0599	CbGbCtD
Clonazepam—CYP3A4—Paclitaxel—kidney cancer	0.0199	0.0549	CbGbCtD
Clonazepam—CYP3A4—Sorafenib—kidney cancer	0.0176	0.0487	CbGbCtD
Clonazepam—CYP3A4—Vinblastine—kidney cancer	0.0174	0.0481	CbGbCtD
Clonazepam—CYP3A4—Vincristine—kidney cancer	0.0171	0.0473	CbGbCtD
Clonazepam—CYP3A4—Sunitinib—kidney cancer	0.0143	0.0395	CbGbCtD
Clonazepam—CYP3A4—Doxorubicin—kidney cancer	0.0107	0.0296	CbGbCtD
Clonazepam—NAT2—renal system—kidney cancer	0.0104	0.118	CbGeAlD
Clonazepam—CYP2E1—urine—kidney cancer	0.00626	0.0711	CbGeAlD
Clonazepam—CYP3A4—urine—kidney cancer	0.00504	0.0572	CbGeAlD
Clonazepam—TSPO—nephron tubule—kidney cancer	0.00292	0.0331	CbGeAlD
Clonazepam—TSPO—renal system—kidney cancer	0.00265	0.0301	CbGeAlD
Clonazepam—TSPO—kidney—kidney cancer	0.00256	0.0291	CbGeAlD
Clonazepam—TSPO—cortex of kidney—kidney cancer	0.0025	0.0283	CbGeAlD
Clonazepam—TSPO—gonad—kidney cancer	0.00238	0.027	CbGeAlD
Clonazepam—TSPO—cardiac atrium—kidney cancer	0.00237	0.027	CbGeAlD
Clonazepam—CYP2E1—nephron tubule—kidney cancer	0.00169	0.0191	CbGeAlD
Clonazepam—Chlorthalidone—CA9—kidney cancer	0.0016	0.37	CrCbGaD
Clonazepam—CYP2E1—renal system—kidney cancer	0.00153	0.0174	CbGeAlD
Clonazepam—CYP2E1—kidney—kidney cancer	0.00148	0.0168	CbGeAlD
Clonazepam—Chlorthalidone—CA2—kidney cancer	0.00144	0.333	CrCbGaD
Clonazepam—CYP2E1—cortex of kidney—kidney cancer	0.00144	0.0164	CbGeAlD
Clonazepam—CYP3A4—renal system—kidney cancer	0.00123	0.014	CbGeAlD
Clonazepam—CYP3A4—kidney—kidney cancer	0.00119	0.0135	CbGeAlD
Clonazepam—Diazepam—PTGS1—kidney cancer	0.000273	0.0628	CrCbGaD
Clonazepam—Clozapine—CYP1A1—kidney cancer	0.000246	0.0567	CrCbGaD
Clonazepam—Nausea—Everolimus—kidney cancer	0.000211	0.000424	CcSEcCtD
Clonazepam—Diarrhoea—Sorafenib—kidney cancer	0.000211	0.000423	CcSEcCtD
Clonazepam—Pruritus—Sunitinib—kidney cancer	0.00021	0.000421	CcSEcCtD
Clonazepam—Immune system disorder—Capecitabine—kidney cancer	0.000208	0.000417	CcSEcCtD
Clonazepam—Myalgia—Paclitaxel—kidney cancer	0.000208	0.000417	CcSEcCtD
Clonazepam—Chest pain—Paclitaxel—kidney cancer	0.000208	0.000417	CcSEcCtD
Clonazepam—Arthralgia—Paclitaxel—kidney cancer	0.000208	0.000417	CcSEcCtD
Clonazepam—Anxiety—Paclitaxel—kidney cancer	0.000208	0.000416	CcSEcCtD
Clonazepam—Face oedema—Doxorubicin—kidney cancer	0.000207	0.000416	CcSEcCtD
Clonazepam—Decreased appetite—Gemcitabine—kidney cancer	0.000207	0.000415	CcSEcCtD
Clonazepam—Hypersensitivity—Dactinomycin—kidney cancer	0.000207	0.000415	CcSEcCtD
Clonazepam—Chills—Capecitabine—kidney cancer	0.000207	0.000415	CcSEcCtD
Clonazepam—Unspecified disorder of skin and subcutaneous tissue—Paclitaxel—kidney cancer	0.000207	0.000415	CcSEcCtD
Clonazepam—Gastrointestinal disorder—Gemcitabine—kidney cancer	0.000206	0.000413	CcSEcCtD
Clonazepam—Discomfort—Paclitaxel—kidney cancer	0.000206	0.000412	CcSEcCtD
Clonazepam—Fatigue—Gemcitabine—kidney cancer	0.000206	0.000412	CcSEcCtD
Clonazepam—Gastrointestinal pain—Vincristine—kidney cancer	0.000206	0.000412	CcSEcCtD
Clonazepam—Cardiac arrest—Doxorubicin—kidney cancer	0.000204	0.000409	CcSEcCtD
Clonazepam—Dizziness—Sorafenib—kidney cancer	0.000204	0.000409	CcSEcCtD
Clonazepam—Pain—Gemcitabine—kidney cancer	0.000204	0.000409	CcSEcCtD
Clonazepam—Constipation—Gemcitabine—kidney cancer	0.000204	0.000409	CcSEcCtD
Clonazepam—Nausea—Erlotinib—kidney cancer	0.000204	0.000409	CcSEcCtD
Clonazepam—Alopecia—Capecitabine—kidney cancer	0.000204	0.000408	CcSEcCtD
Clonazepam—Dry mouth—Paclitaxel—kidney cancer	0.000204	0.000408	CcSEcCtD
Clonazepam—Mood swings—Doxorubicin—kidney cancer	0.000204	0.000408	CcSEcCtD
Clonazepam—Diarrhoea—Sunitinib—kidney cancer	0.000203	0.000408	CcSEcCtD
Clonazepam—Ataxia—Doxorubicin—kidney cancer	0.000202	0.000405	CcSEcCtD
Clonazepam—Mental disorder—Capecitabine—kidney cancer	0.000202	0.000405	CcSEcCtD
Clonazepam—Asthenia—Dactinomycin—kidney cancer	0.000202	0.000405	CcSEcCtD
Clonazepam—Confusional state—Paclitaxel—kidney cancer	0.000201	0.000403	CcSEcCtD
Clonazepam—Malnutrition—Capecitabine—kidney cancer	0.000201	0.000402	CcSEcCtD
Clonazepam—Dehydration—Doxorubicin—kidney cancer	0.0002	0.0004	CcSEcCtD
Clonazepam—Oedema—Paclitaxel—kidney cancer	0.0002	0.0004	CcSEcCtD
Clonazepam—Anaphylactic shock—Paclitaxel—kidney cancer	0.0002	0.0004	CcSEcCtD
Clonazepam—Body temperature increased—Vincristine—kidney cancer	0.000199	0.000398	CcSEcCtD
Clonazepam—Abdominal pain—Vincristine—kidney cancer	0.000199	0.000398	CcSEcCtD
Clonazepam—Liver function test abnormal—Doxorubicin—kidney cancer	0.000198	0.000398	CcSEcCtD
Clonazepam—Infection—Paclitaxel—kidney cancer	0.000198	0.000398	CcSEcCtD
Clonazepam—Flatulence—Capecitabine—kidney cancer	0.000198	0.000396	CcSEcCtD
Clonazepam—Dizziness—Sunitinib—kidney cancer	0.000197	0.000394	CcSEcCtD
Clonazepam—Feeling abnormal—Gemcitabine—kidney cancer	0.000197	0.000394	CcSEcCtD
Clonazepam—Vomiting—Sorafenib—kidney cancer	0.000196	0.000394	CcSEcCtD
Clonazepam—Orthostatic hypotension—Doxorubicin—kidney cancer	0.000196	0.000393	CcSEcCtD
Clonazepam—Nervous system disorder—Paclitaxel—kidney cancer	0.000196	0.000392	CcSEcCtD
Clonazepam—Thrombocytopenia—Paclitaxel—kidney cancer	0.000195	0.000392	CcSEcCtD
Clonazepam—Tachycardia—Paclitaxel—kidney cancer	0.000195	0.000391	CcSEcCtD
Clonazepam—Rash—Sorafenib—kidney cancer	0.000195	0.00039	CcSEcCtD
Clonazepam—Dermatitis—Sorafenib—kidney cancer	0.000195	0.00039	CcSEcCtD
Clonazepam—Back pain—Capecitabine—kidney cancer	0.000194	0.000389	CcSEcCtD
Clonazepam—Breast disorder—Doxorubicin—kidney cancer	0.000194	0.000389	CcSEcCtD
Clonazepam—Skin disorder—Paclitaxel—kidney cancer	0.000194	0.000389	CcSEcCtD
Clonazepam—Headache—Sorafenib—kidney cancer	0.000194	0.000388	CcSEcCtD
Clonazepam—Muscle spasms—Capecitabine—kidney cancer	0.000193	0.000387	CcSEcCtD
Clonazepam—Diarrhoea—Dactinomycin—kidney cancer	0.000193	0.000386	CcSEcCtD
Clonazepam—Nasopharyngitis—Doxorubicin—kidney cancer	0.000192	0.000385	CcSEcCtD
Clonazepam—Anorexia—Paclitaxel—kidney cancer	0.00019	0.000381	CcSEcCtD
Clonazepam—Gastritis—Doxorubicin—kidney cancer	0.00019	0.000381	CcSEcCtD
Clonazepam—Muscular weakness—Doxorubicin—kidney cancer	0.00019	0.00038	CcSEcCtD
Clonazepam—Vision blurred—Capecitabine—kidney cancer	0.000189	0.000379	CcSEcCtD
Clonazepam—Vomiting—Sunitinib—kidney cancer	0.000189	0.000379	CcSEcCtD
Clonazepam—Body temperature increased—Gemcitabine—kidney cancer	0.000189	0.000378	CcSEcCtD
Clonazepam—Tremor—Capecitabine—kidney cancer	0.000188	0.000377	CcSEcCtD
Clonazepam—Nitrazepam—ABCB1—kidney cancer	0.000188	0.0432	CrCbGaD
Clonazepam—Rash—Sunitinib—kidney cancer	0.000187	0.000376	CcSEcCtD
Clonazepam—Dermatitis—Sunitinib—kidney cancer	0.000187	0.000375	CcSEcCtD
Clonazepam—Hypotension—Paclitaxel—kidney cancer	0.000187	0.000374	CcSEcCtD
Clonazepam—Ill-defined disorder—Capecitabine—kidney cancer	0.000186	0.000373	CcSEcCtD
Clonazepam—Headache—Sunitinib—kidney cancer	0.000186	0.000373	CcSEcCtD
Clonazepam—Dysphagia—Doxorubicin—kidney cancer	0.000186	0.000372	CcSEcCtD
Clonazepam—Influenza—Doxorubicin—kidney cancer	0.000186	0.000372	CcSEcCtD
Clonazepam—Asthma—Doxorubicin—kidney cancer	0.000186	0.000372	CcSEcCtD
Clonazepam—Anaemia—Capecitabine—kidney cancer	0.000186	0.000372	CcSEcCtD
Clonazepam—Hypersensitivity—Vincristine—kidney cancer	0.000185	0.000371	CcSEcCtD
Clonazepam—Eosinophilia—Doxorubicin—kidney cancer	0.000184	0.000369	CcSEcCtD
Clonazepam—Nausea—Sorafenib—kidney cancer	0.000183	0.000368	CcSEcCtD
Clonazepam—Musculoskeletal discomfort—Paclitaxel—kidney cancer	0.000182	0.000365	CcSEcCtD
Clonazepam—Malaise—Capecitabine—kidney cancer	0.000181	0.000363	CcSEcCtD
Clonazepam—Insomnia—Paclitaxel—kidney cancer	0.000181	0.000362	CcSEcCtD
Clonazepam—Vertigo—Capecitabine—kidney cancer	0.00018	0.000361	CcSEcCtD
Clonazepam—Asthenia—Vincristine—kidney cancer	0.00018	0.000361	CcSEcCtD
Clonazepam—Leukopenia—Capecitabine—kidney cancer	0.00018	0.00036	CcSEcCtD
Clonazepam—Vomiting—Dactinomycin—kidney cancer	0.000179	0.000358	CcSEcCtD
Clonazepam—Bronchitis—Doxorubicin—kidney cancer	0.000179	0.000358	CcSEcCtD
Clonazepam—Dyspnoea—Paclitaxel—kidney cancer	0.000178	0.000357	CcSEcCtD
Clonazepam—Somnolence—Paclitaxel—kidney cancer	0.000178	0.000356	CcSEcCtD
Clonazepam—Palpitations—Capecitabine—kidney cancer	0.000177	0.000356	CcSEcCtD
Clonazepam—Rash—Dactinomycin—kidney cancer	0.000177	0.000356	CcSEcCtD
Clonazepam—Nausea—Sunitinib—kidney cancer	0.000177	0.000354	CcSEcCtD
Clonazepam—Dyspepsia—Paclitaxel—kidney cancer	0.000176	0.000352	CcSEcCtD
Clonazepam—Cough—Capecitabine—kidney cancer	0.000175	0.000351	CcSEcCtD
Clonazepam—Dysuria—Doxorubicin—kidney cancer	0.000174	0.000348	CcSEcCtD
Clonazepam—Decreased appetite—Paclitaxel—kidney cancer	0.000174	0.000348	CcSEcCtD
Clonazepam—Upper respiratory tract infection—Doxorubicin—kidney cancer	0.000173	0.000346	CcSEcCtD
Clonazepam—Gastrointestinal disorder—Paclitaxel—kidney cancer	0.000172	0.000345	CcSEcCtD
Clonazepam—Fatigue—Paclitaxel—kidney cancer	0.000172	0.000345	CcSEcCtD
Clonazepam—Diarrhoea—Vincristine—kidney cancer	0.000172	0.000345	CcSEcCtD
Clonazepam—Pollakiuria—Doxorubicin—kidney cancer	0.000172	0.000344	CcSEcCtD
Clonazepam—Asthenia—Gemcitabine—kidney cancer	0.000171	0.000343	CcSEcCtD
Clonazepam—Arthralgia—Capecitabine—kidney cancer	0.000171	0.000343	CcSEcCtD
Clonazepam—Chest pain—Capecitabine—kidney cancer	0.000171	0.000343	CcSEcCtD
Clonazepam—Myalgia—Capecitabine—kidney cancer	0.000171	0.000343	CcSEcCtD
Clonazepam—Pain—Paclitaxel—kidney cancer	0.000171	0.000342	CcSEcCtD
Clonazepam—Constipation—Paclitaxel—kidney cancer	0.000171	0.000342	CcSEcCtD
Clonazepam—Anxiety—Capecitabine—kidney cancer	0.00017	0.000341	CcSEcCtD
Clonazepam—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—kidney cancer	0.00017	0.00034	CcSEcCtD
Clonazepam—Weight increased—Doxorubicin—kidney cancer	0.000169	0.000339	CcSEcCtD
Clonazepam—Discomfort—Capecitabine—kidney cancer	0.000169	0.000338	CcSEcCtD
Clonazepam—Pruritus—Gemcitabine—kidney cancer	0.000169	0.000338	CcSEcCtD
Clonazepam—Weight decreased—Doxorubicin—kidney cancer	0.000168	0.000337	CcSEcCtD
Clonazepam—Dry mouth—Capecitabine—kidney cancer	0.000167	0.000335	CcSEcCtD
Clonazepam—Nausea—Dactinomycin—kidney cancer	0.000167	0.000335	CcSEcCtD
Clonazepam—Flurazepam—ABCB1—kidney cancer	0.000167	0.0384	CrCbGaD
Clonazepam—Pneumonia—Doxorubicin—kidney cancer	0.000167	0.000334	CcSEcCtD
Clonazepam—Dizziness—Vincristine—kidney cancer	0.000166	0.000333	CcSEcCtD
Clonazepam—Drowsiness—Doxorubicin—kidney cancer	0.000166	0.000332	CcSEcCtD
Clonazepam—Confusional state—Capecitabine—kidney cancer	0.000165	0.000331	CcSEcCtD
Clonazepam—Feeling abnormal—Paclitaxel—kidney cancer	0.000165	0.00033	CcSEcCtD
Clonazepam—Oedema—Capecitabine—kidney cancer	0.000164	0.000328	CcSEcCtD
Clonazepam—Gastrointestinal pain—Paclitaxel—kidney cancer	0.000163	0.000327	CcSEcCtD
Clonazepam—Diarrhoea—Gemcitabine—kidney cancer	0.000163	0.000327	CcSEcCtD
Clonazepam—Infection—Capecitabine—kidney cancer	0.000163	0.000326	CcSEcCtD
Clonazepam—Neuropathy peripheral—Doxorubicin—kidney cancer	0.000162	0.000325	CcSEcCtD
Clonazepam—Urinary tract infection—Doxorubicin—kidney cancer	0.000161	0.000323	CcSEcCtD
Clonazepam—Nervous system disorder—Capecitabine—kidney cancer	0.000161	0.000322	CcSEcCtD
Clonazepam—Thrombocytopenia—Capecitabine—kidney cancer	0.00016	0.000321	CcSEcCtD
Clonazepam—Tachycardia—Capecitabine—kidney cancer	0.00016	0.00032	CcSEcCtD
Clonazepam—Vomiting—Vincristine—kidney cancer	0.00016	0.00032	CcSEcCtD
Clonazepam—Skin disorder—Capecitabine—kidney cancer	0.000159	0.000319	CcSEcCtD
Clonazepam—Urticaria—Paclitaxel—kidney cancer	0.000159	0.000318	CcSEcCtD
Clonazepam—Rash—Vincristine—kidney cancer	0.000159	0.000318	CcSEcCtD
Clonazepam—Dermatitis—Vincristine—kidney cancer	0.000158	0.000317	CcSEcCtD
Clonazepam—Body temperature increased—Paclitaxel—kidney cancer	0.000158	0.000316	CcSEcCtD
Clonazepam—Abdominal pain—Paclitaxel—kidney cancer	0.000158	0.000316	CcSEcCtD
Clonazepam—Headache—Vincristine—kidney cancer	0.000157	0.000316	CcSEcCtD
Clonazepam—Epistaxis—Doxorubicin—kidney cancer	0.000156	0.000313	CcSEcCtD
Clonazepam—Anorexia—Capecitabine—kidney cancer	0.000156	0.000313	CcSEcCtD
Clonazepam—Sinusitis—Doxorubicin—kidney cancer	0.000155	0.000311	CcSEcCtD
Clonazepam—Midazolam—ABCB1—kidney cancer	0.000155	0.0356	CrCbGaD
Clonazepam—Hypotension—Capecitabine—kidney cancer	0.000153	0.000307	CcSEcCtD
Clonazepam—Vomiting—Gemcitabine—kidney cancer	0.000152	0.000304	CcSEcCtD
Clonazepam—Rash—Gemcitabine—kidney cancer	0.00015	0.000301	CcSEcCtD
Clonazepam—Dermatitis—Gemcitabine—kidney cancer	0.00015	0.000301	CcSEcCtD
Clonazepam—Haemoglobin—Doxorubicin—kidney cancer	0.000149	0.000299	CcSEcCtD
Clonazepam—Headache—Gemcitabine—kidney cancer	0.000149	0.000299	CcSEcCtD
Clonazepam—Nausea—Vincristine—kidney cancer	0.000149	0.000299	CcSEcCtD
Clonazepam—Musculoskeletal discomfort—Capecitabine—kidney cancer	0.000149	0.000299	CcSEcCtD
Clonazepam—Rhinitis—Doxorubicin—kidney cancer	0.000149	0.000299	CcSEcCtD
Clonazepam—Haemorrhage—Doxorubicin—kidney cancer	0.000149	0.000298	CcSEcCtD
Clonazepam—Insomnia—Capecitabine—kidney cancer	0.000148	0.000297	CcSEcCtD
Clonazepam—Hypoaesthesia—Doxorubicin—kidney cancer	0.000148	0.000296	CcSEcCtD
Clonazepam—Pharyngitis—Doxorubicin—kidney cancer	0.000148	0.000296	CcSEcCtD
Clonazepam—Hypersensitivity—Paclitaxel—kidney cancer	0.000147	0.000295	CcSEcCtD
Clonazepam—Urinary tract disorder—Doxorubicin—kidney cancer	0.000147	0.000294	CcSEcCtD
Clonazepam—Oedema peripheral—Doxorubicin—kidney cancer	0.000146	0.000293	CcSEcCtD
Clonazepam—Connective tissue disorder—Doxorubicin—kidney cancer	0.000146	0.000293	CcSEcCtD
Clonazepam—Dyspnoea—Capecitabine—kidney cancer	0.000146	0.000293	CcSEcCtD
Clonazepam—Urethral disorder—Doxorubicin—kidney cancer	0.000146	0.000292	CcSEcCtD
Clonazepam—Dyspepsia—Capecitabine—kidney cancer	0.000144	0.000289	CcSEcCtD
Clonazepam—Visual impairment—Doxorubicin—kidney cancer	0.000143	0.000287	CcSEcCtD
Clonazepam—Asthenia—Paclitaxel—kidney cancer	0.000143	0.000287	CcSEcCtD
Clonazepam—Decreased appetite—Capecitabine—kidney cancer	0.000142	0.000285	CcSEcCtD
Clonazepam—Nausea—Gemcitabine—kidney cancer	0.000142	0.000284	CcSEcCtD
Clonazepam—Gastrointestinal disorder—Capecitabine—kidney cancer	0.000141	0.000283	CcSEcCtD
Clonazepam—Fatigue—Capecitabine—kidney cancer	0.000141	0.000283	CcSEcCtD
Clonazepam—Pruritus—Paclitaxel—kidney cancer	0.000141	0.000283	CcSEcCtD
Clonazepam—Pain—Capecitabine—kidney cancer	0.00014	0.000281	CcSEcCtD
Clonazepam—Constipation—Capecitabine—kidney cancer	0.00014	0.000281	CcSEcCtD
Clonazepam—Eye disorder—Doxorubicin—kidney cancer	0.000139	0.000278	CcSEcCtD
Clonazepam—Flushing—Doxorubicin—kidney cancer	0.000138	0.000276	CcSEcCtD
Clonazepam—Cardiac disorder—Doxorubicin—kidney cancer	0.000138	0.000276	CcSEcCtD
Clonazepam—Diarrhoea—Paclitaxel—kidney cancer	0.000137	0.000274	CcSEcCtD
Clonazepam—Feeling abnormal—Capecitabine—kidney cancer	0.000135	0.000271	CcSEcCtD
Clonazepam—Immune system disorder—Doxorubicin—kidney cancer	0.000134	0.000269	CcSEcCtD
Clonazepam—Gastrointestinal pain—Capecitabine—kidney cancer	0.000134	0.000268	CcSEcCtD
Clonazepam—Chills—Doxorubicin—kidney cancer	0.000133	0.000267	CcSEcCtD
Clonazepam—Diazepam—ABCB1—kidney cancer	0.000132	0.0305	CrCbGaD
Clonazepam—Dizziness—Paclitaxel—kidney cancer	0.000132	0.000265	CcSEcCtD
Clonazepam—Alopecia—Doxorubicin—kidney cancer	0.000131	0.000263	CcSEcCtD
Clonazepam—Clozapine—ABCB1—kidney cancer	0.000131	0.0301	CrCbGaD
Clonazepam—Mental disorder—Doxorubicin—kidney cancer	0.00013	0.000261	CcSEcCtD
Clonazepam—Urticaria—Capecitabine—kidney cancer	0.00013	0.000261	CcSEcCtD
Clonazepam—Body temperature increased—Capecitabine—kidney cancer	0.00013	0.00026	CcSEcCtD
Clonazepam—Abdominal pain—Capecitabine—kidney cancer	0.00013	0.00026	CcSEcCtD
Clonazepam—Malnutrition—Doxorubicin—kidney cancer	0.000129	0.000259	CcSEcCtD
Clonazepam—Flatulence—Doxorubicin—kidney cancer	0.000128	0.000256	CcSEcCtD
Clonazepam—Tension—Doxorubicin—kidney cancer	0.000127	0.000254	CcSEcCtD
Clonazepam—Vomiting—Paclitaxel—kidney cancer	0.000127	0.000254	CcSEcCtD
Clonazepam—Rash—Paclitaxel—kidney cancer	0.000126	0.000252	CcSEcCtD
Clonazepam—Dermatitis—Paclitaxel—kidney cancer	0.000126	0.000252	CcSEcCtD
Clonazepam—Nervousness—Doxorubicin—kidney cancer	0.000126	0.000252	CcSEcCtD
Clonazepam—Back pain—Doxorubicin—kidney cancer	0.000125	0.000251	CcSEcCtD
Clonazepam—Headache—Paclitaxel—kidney cancer	0.000125	0.000251	CcSEcCtD
Clonazepam—Muscle spasms—Doxorubicin—kidney cancer	0.000124	0.000249	CcSEcCtD
Clonazepam—Vision blurred—Doxorubicin—kidney cancer	0.000122	0.000244	CcSEcCtD
Clonazepam—Hypersensitivity—Capecitabine—kidney cancer	0.000121	0.000242	CcSEcCtD
Clonazepam—Ill-defined disorder—Doxorubicin—kidney cancer	0.00012	0.000241	CcSEcCtD
Clonazepam—Anaemia—Doxorubicin—kidney cancer	0.00012	0.00024	CcSEcCtD
Clonazepam—Agitation—Doxorubicin—kidney cancer	0.000119	0.000238	CcSEcCtD
Clonazepam—Nausea—Paclitaxel—kidney cancer	0.000119	0.000238	CcSEcCtD
Clonazepam—Asthenia—Capecitabine—kidney cancer	0.000118	0.000236	CcSEcCtD
Clonazepam—Malaise—Doxorubicin—kidney cancer	0.000117	0.000234	CcSEcCtD
Clonazepam—Vertigo—Doxorubicin—kidney cancer	0.000116	0.000233	CcSEcCtD
Clonazepam—Pruritus—Capecitabine—kidney cancer	0.000116	0.000232	CcSEcCtD
Clonazepam—Leukopenia—Doxorubicin—kidney cancer	0.000116	0.000232	CcSEcCtD
Clonazepam—Palpitations—Doxorubicin—kidney cancer	0.000114	0.000229	CcSEcCtD
Clonazepam—Cough—Doxorubicin—kidney cancer	0.000113	0.000226	CcSEcCtD
Clonazepam—Diarrhoea—Capecitabine—kidney cancer	0.000112	0.000225	CcSEcCtD
Clonazepam—Chest pain—Doxorubicin—kidney cancer	0.00011	0.000221	CcSEcCtD
Clonazepam—Myalgia—Doxorubicin—kidney cancer	0.00011	0.000221	CcSEcCtD
Clonazepam—Arthralgia—Doxorubicin—kidney cancer	0.00011	0.000221	CcSEcCtD
Clonazepam—Anxiety—Doxorubicin—kidney cancer	0.00011	0.00022	CcSEcCtD
Clonazepam—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—kidney cancer	0.000109	0.000219	CcSEcCtD
Clonazepam—Discomfort—Doxorubicin—kidney cancer	0.000109	0.000218	CcSEcCtD
Clonazepam—Dizziness—Capecitabine—kidney cancer	0.000108	0.000217	CcSEcCtD
Clonazepam—Dry mouth—Doxorubicin—kidney cancer	0.000108	0.000216	CcSEcCtD
Clonazepam—Confusional state—Doxorubicin—kidney cancer	0.000107	0.000213	CcSEcCtD
Clonazepam—Oedema—Doxorubicin—kidney cancer	0.000106	0.000212	CcSEcCtD
Clonazepam—Anaphylactic shock—Doxorubicin—kidney cancer	0.000106	0.000212	CcSEcCtD
Clonazepam—Infection—Doxorubicin—kidney cancer	0.000105	0.00021	CcSEcCtD
Clonazepam—Vomiting—Capecitabine—kidney cancer	0.000104	0.000209	CcSEcCtD
Clonazepam—Nervous system disorder—Doxorubicin—kidney cancer	0.000104	0.000208	CcSEcCtD
Clonazepam—Thrombocytopenia—Doxorubicin—kidney cancer	0.000103	0.000207	CcSEcCtD
Clonazepam—Rash—Capecitabine—kidney cancer	0.000103	0.000207	CcSEcCtD
Clonazepam—Dermatitis—Capecitabine—kidney cancer	0.000103	0.000207	CcSEcCtD
Clonazepam—Tachycardia—Doxorubicin—kidney cancer	0.000103	0.000207	CcSEcCtD
Clonazepam—Headache—Capecitabine—kidney cancer	0.000103	0.000206	CcSEcCtD
Clonazepam—Skin disorder—Doxorubicin—kidney cancer	0.000103	0.000206	CcSEcCtD
Clonazepam—Anorexia—Doxorubicin—kidney cancer	0.000101	0.000202	CcSEcCtD
Clonazepam—Hypotension—Doxorubicin—kidney cancer	9.87e-05	0.000198	CcSEcCtD
Clonazepam—Nausea—Capecitabine—kidney cancer	9.73e-05	0.000195	CcSEcCtD
Clonazepam—Musculoskeletal discomfort—Doxorubicin—kidney cancer	9.62e-05	0.000193	CcSEcCtD
Clonazepam—Insomnia—Doxorubicin—kidney cancer	9.55e-05	0.000191	CcSEcCtD
Clonazepam—Dyspnoea—Doxorubicin—kidney cancer	9.42e-05	0.000189	CcSEcCtD
Clonazepam—Somnolence—Doxorubicin—kidney cancer	9.39e-05	0.000188	CcSEcCtD
Clonazepam—Dyspepsia—Doxorubicin—kidney cancer	9.3e-05	0.000186	CcSEcCtD
Clonazepam—Decreased appetite—Doxorubicin—kidney cancer	9.18e-05	0.000184	CcSEcCtD
Clonazepam—Gastrointestinal disorder—Doxorubicin—kidney cancer	9.12e-05	0.000183	CcSEcCtD
Clonazepam—Fatigue—Doxorubicin—kidney cancer	9.11e-05	0.000182	CcSEcCtD
Clonazepam—Constipation—Doxorubicin—kidney cancer	9.03e-05	0.000181	CcSEcCtD
Clonazepam—Pain—Doxorubicin—kidney cancer	9.03e-05	0.000181	CcSEcCtD
Clonazepam—Feeling abnormal—Doxorubicin—kidney cancer	8.7e-05	0.000174	CcSEcCtD
Clonazepam—Gastrointestinal pain—Doxorubicin—kidney cancer	8.64e-05	0.000173	CcSEcCtD
Clonazepam—GABRB2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—RAF1—kidney cancer	8.58e-05	0.00185	CbGpPWpGaD
Clonazepam—CYP3A4—Phase 1 - Functionalization of compounds—PTGS1—kidney cancer	8.55e-05	0.00184	CbGpPWpGaD
Clonazepam—NAT2—Metabolism—GSTT1—kidney cancer	8.43e-05	0.00181	CbGpPWpGaD
Clonazepam—NAT2—Metabolism—ACHE—kidney cancer	8.43e-05	0.00181	CbGpPWpGaD
Clonazepam—CYP3A4—Tryptophan metabolism—CYP1A1—kidney cancer	8.4e-05	0.00181	CbGpPWpGaD
Clonazepam—Urticaria—Doxorubicin—kidney cancer	8.39e-05	0.000168	CcSEcCtD
Clonazepam—Body temperature increased—Doxorubicin—kidney cancer	8.35e-05	0.000167	CcSEcCtD
Clonazepam—Abdominal pain—Doxorubicin—kidney cancer	8.35e-05	0.000167	CcSEcCtD
Clonazepam—CYP3A4—Biological oxidations—ALDH1A1—kidney cancer	8.25e-05	0.00177	CbGpPWpGaD
Clonazepam—GABRA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—BRAF—kidney cancer	8.22e-05	0.00177	CbGpPWpGaD
Clonazepam—GABRA3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—RAF1—kidney cancer	8.19e-05	0.00176	CbGpPWpGaD
Clonazepam—ALB—Hemostasis—L1CAM—kidney cancer	8.15e-05	0.00175	CbGpPWpGaD
Clonazepam—CYP2E1—Vitamin A and Carotenoid Metabolism—MAPK1—kidney cancer	8.06e-05	0.00173	CbGpPWpGaD
Clonazepam—ALB—Platelet activation, signaling and aggregation—ITPR2—kidney cancer	8.05e-05	0.00173	CbGpPWpGaD
Clonazepam—NAT2—Metabolism—SCARB1—kidney cancer	7.98e-05	0.00171	CbGpPWpGaD
Clonazepam—NAT2—Metabolism—PTGS1—kidney cancer	7.9e-05	0.0017	CbGpPWpGaD
Clonazepam—GABRG2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—RAF1—kidney cancer	7.85e-05	0.00169	CbGpPWpGaD
Clonazepam—Hypersensitivity—Doxorubicin—kidney cancer	7.78e-05	0.000156	CcSEcCtD
Clonazepam—NAT2—Metabolism—PSMD7—kidney cancer	7.74e-05	0.00166	CbGpPWpGaD
Clonazepam—GABRB2—Transmission across Chemical Synapses—BRAF—kidney cancer	7.73e-05	0.00166	CbGpPWpGaD
Clonazepam—GABRB2—Ion channel transport—RAF1—kidney cancer	7.64e-05	0.00164	CbGpPWpGaD
Clonazepam—Asthenia—Doxorubicin—kidney cancer	7.58e-05	0.000152	CcSEcCtD
Clonazepam—Pruritus—Doxorubicin—kidney cancer	7.47e-05	0.00015	CcSEcCtD
Clonazepam—ALB—Metabolism of lipids and lipoproteins—GLIPR1—kidney cancer	7.42e-05	0.0016	CbGpPWpGaD
Clonazepam—GABRA3—Transmission across Chemical Synapses—BRAF—kidney cancer	7.37e-05	0.00159	CbGpPWpGaD
Clonazepam—NAT2—Metabolism—BCHE—kidney cancer	7.34e-05	0.00158	CbGpPWpGaD
Clonazepam—GABRA3—Ion channel transport—RAF1—kidney cancer	7.29e-05	0.00157	CbGpPWpGaD
Clonazepam—NAT2—Metabolism—SLC5A5—kidney cancer	7.25e-05	0.00156	CbGpPWpGaD
Clonazepam—CYP2E1—Biological oxidations—GSTP1—kidney cancer	7.24e-05	0.00156	CbGpPWpGaD
Clonazepam—Diarrhoea—Doxorubicin—kidney cancer	7.23e-05	0.000145	CcSEcCtD
Clonazepam—CYP2E1—Metapathway biotransformation—GSTP1—kidney cancer	7.14e-05	0.00154	CbGpPWpGaD
Clonazepam—ALB—Folate Metabolism—RELA—kidney cancer	7.14e-05	0.00153	CbGpPWpGaD
Clonazepam—GABRG2—Transmission across Chemical Synapses—BRAF—kidney cancer	7.07e-05	0.00152	CbGpPWpGaD
Clonazepam—NAT2—Metabolism—SLC2A1—kidney cancer	7e-05	0.00151	CbGpPWpGaD
Clonazepam—GABRG2—Ion channel transport—RAF1—kidney cancer	6.99e-05	0.0015	CbGpPWpGaD
Clonazepam—Dizziness—Doxorubicin—kidney cancer	6.98e-05	0.00014	CcSEcCtD
Clonazepam—GABRA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—RAF1—kidney cancer	6.86e-05	0.00148	CbGpPWpGaD
Clonazepam—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1A1—kidney cancer	6.79e-05	0.00146	CbGpPWpGaD
Clonazepam—Vomiting—Doxorubicin—kidney cancer	6.72e-05	0.000135	CcSEcCtD
Clonazepam—CYP3A4—Oxidation by Cytochrome P450—CYP1A1—kidney cancer	6.71e-05	0.00144	CbGpPWpGaD
Clonazepam—Rash—Doxorubicin—kidney cancer	6.66e-05	0.000133	CcSEcCtD
Clonazepam—Dermatitis—Doxorubicin—kidney cancer	6.65e-05	0.000133	CcSEcCtD
Clonazepam—CYP2E1—Biological oxidations—GSTM1—kidney cancer	6.65e-05	0.00143	CbGpPWpGaD
Clonazepam—Headache—Doxorubicin—kidney cancer	6.62e-05	0.000133	CcSEcCtD
Clonazepam—CYP2E1—Metapathway biotransformation—GSTM1—kidney cancer	6.56e-05	0.00141	CbGpPWpGaD
Clonazepam—GABRB2—Transmission across Chemical Synapses—RAF1—kidney cancer	6.45e-05	0.00139	CbGpPWpGaD
Clonazepam—ALB—Folate Metabolism—IL2—kidney cancer	6.43e-05	0.00138	CbGpPWpGaD
Clonazepam—CYP2E1—Biological oxidations—CYP1A1—kidney cancer	6.31e-05	0.00136	CbGpPWpGaD
Clonazepam—Nausea—Doxorubicin—kidney cancer	6.27e-05	0.000126	CcSEcCtD
Clonazepam—CYP2E1—Metapathway biotransformation—CYP1A1—kidney cancer	6.22e-05	0.00134	CbGpPWpGaD
Clonazepam—GABRA1—Transmission across Chemical Synapses—BRAF—kidney cancer	6.18e-05	0.00133	CbGpPWpGaD
Clonazepam—ALB—Hemostasis—ANXA2—kidney cancer	6.18e-05	0.00133	CbGpPWpGaD
Clonazepam—GABRB2—Transmembrane transport of small molecules—SLC5A5—kidney cancer	6.16e-05	0.00132	CbGpPWpGaD
Clonazepam—GABRA3—Transmission across Chemical Synapses—RAF1—kidney cancer	6.16e-05	0.00132	CbGpPWpGaD
Clonazepam—GABRA1—Ion channel transport—RAF1—kidney cancer	6.11e-05	0.00131	CbGpPWpGaD
Clonazepam—GABRB2—Transmembrane transport of small molecules—SLC2A1—kidney cancer	5.95e-05	0.00128	CbGpPWpGaD
Clonazepam—GABRB2—Neuronal System—BRAF—kidney cancer	5.92e-05	0.00127	CbGpPWpGaD
Clonazepam—GABRG2—Transmission across Chemical Synapses—RAF1—kidney cancer	5.9e-05	0.00127	CbGpPWpGaD
Clonazepam—GABRB2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MAPK1—kidney cancer	5.89e-05	0.00127	CbGpPWpGaD
Clonazepam—GABRA3—Transmembrane transport of small molecules—SLC5A5—kidney cancer	5.88e-05	0.00126	CbGpPWpGaD
Clonazepam—NAT2—Metabolism—GSTP1—kidney cancer	5.84e-05	0.00126	CbGpPWpGaD
Clonazepam—GABRA3—Transmembrane transport of small molecules—SLC2A1—kidney cancer	5.68e-05	0.00122	CbGpPWpGaD
Clonazepam—ALB—Selenium Micronutrient Network—RELA—kidney cancer	5.67e-05	0.00122	CbGpPWpGaD
Clonazepam—GABRA3—Neuronal System—BRAF—kidney cancer	5.65e-05	0.00121	CbGpPWpGaD
Clonazepam—GABRG2—Transmembrane transport of small molecules—SLC5A5—kidney cancer	5.64e-05	0.00121	CbGpPWpGaD
Clonazepam—GABRA3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MAPK1—kidney cancer	5.62e-05	0.00121	CbGpPWpGaD
Clonazepam—ALB—SLC-mediated transmembrane transport—SLC5A5—kidney cancer	5.55e-05	0.00119	CbGpPWpGaD
Clonazepam—CYP2E1—Metabolism—ACY1—kidney cancer	5.55e-05	0.00119	CbGpPWpGaD
Clonazepam—NAT2—Metabolism—ABCB1—kidney cancer	5.53e-05	0.00119	CbGpPWpGaD
Clonazepam—ALB—Selenium Micronutrient Network—PTGS2—kidney cancer	5.51e-05	0.00118	CbGpPWpGaD
Clonazepam—CYP3A4—Phase 1 - Functionalization of compounds—CYP1A1—kidney cancer	5.51e-05	0.00118	CbGpPWpGaD
Clonazepam—GABRA1—SIDS Susceptibility Pathways—JUN—kidney cancer	5.49e-05	0.00118	CbGpPWpGaD
Clonazepam—GABRA1—SIDS Susceptibility Pathways—CTNNB1—kidney cancer	5.45e-05	0.00117	CbGpPWpGaD
Clonazepam—GABRG2—Transmembrane transport of small molecules—SLC2A1—kidney cancer	5.44e-05	0.00117	CbGpPWpGaD
Clonazepam—GABRG2—Neuronal System—BRAF—kidney cancer	5.42e-05	0.00116	CbGpPWpGaD
Clonazepam—GABRG2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MAPK1—kidney cancer	5.38e-05	0.00116	CbGpPWpGaD
Clonazepam—NAT2—Metabolism—GSTM1—kidney cancer	5.37e-05	0.00115	CbGpPWpGaD
Clonazepam—ALB—SLC-mediated transmembrane transport—SLC2A1—kidney cancer	5.36e-05	0.00115	CbGpPWpGaD
Clonazepam—ALB—Transmembrane transport of small molecules—SLC5A3—kidney cancer	5.35e-05	0.00115	CbGpPWpGaD
Clonazepam—ALB—Transmembrane transport of small molecules—ATP7B—kidney cancer	5.35e-05	0.00115	CbGpPWpGaD
Clonazepam—ALB—Transmembrane transport of small molecules—ANXA2—kidney cancer	5.35e-05	0.00115	CbGpPWpGaD
Clonazepam—GABRA1—Transmission across Chemical Synapses—RAF1—kidney cancer	5.16e-05	0.00111	CbGpPWpGaD
Clonazepam—ALB—Hemostasis—KCNMA1—kidney cancer	5.12e-05	0.0011	CbGpPWpGaD
Clonazepam—NAT2—Metabolism—CYP1A1—kidney cancer	5.09e-05	0.00109	CbGpPWpGaD
Clonazepam—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—kidney cancer	5.07e-05	0.00109	CbGpPWpGaD
Clonazepam—ALB—Platelet activation, signaling and aggregation—IGF2—kidney cancer	4.95e-05	0.00107	CbGpPWpGaD
Clonazepam—GABRB2—Neuronal System—RAF1—kidney cancer	4.94e-05	0.00106	CbGpPWpGaD
Clonazepam—GABRA1—Transmembrane transport of small molecules—SLC5A5—kidney cancer	4.93e-05	0.00106	CbGpPWpGaD
Clonazepam—CYP3A4—Biological oxidations—GSTT1—kidney cancer	4.85e-05	0.00104	CbGpPWpGaD
Clonazepam—GABRA1—SIDS Susceptibility Pathways—VEGFA—kidney cancer	4.8e-05	0.00103	CbGpPWpGaD
Clonazepam—ALB—Metabolism—ACY1—kidney cancer	4.77e-05	0.00103	CbGpPWpGaD
Clonazepam—GABRA1—Transmembrane transport of small molecules—SLC2A1—kidney cancer	4.76e-05	0.00102	CbGpPWpGaD
Clonazepam—GABRA1—Neuronal System—BRAF—kidney cancer	4.73e-05	0.00102	CbGpPWpGaD
Clonazepam—GABRA3—Neuronal System—RAF1—kidney cancer	4.72e-05	0.00101	CbGpPWpGaD
Clonazepam—CYP2E1—Metabolism—PDHB—kidney cancer	4.72e-05	0.00101	CbGpPWpGaD
Clonazepam—GABRA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MAPK1—kidney cancer	4.71e-05	0.00101	CbGpPWpGaD
Clonazepam—CYP2E1—Biological oxidations—POMC—kidney cancer	4.7e-05	0.00101	CbGpPWpGaD
Clonazepam—GABRB2—Transmembrane transport of small molecules—ABCB1—kidney cancer	4.7e-05	0.00101	CbGpPWpGaD
Clonazepam—ALB—Platelet degranulation—VEGFA—kidney cancer	4.68e-05	0.00101	CbGpPWpGaD
Clonazepam—CYP3A4—Biological oxidations—PTGS1—kidney cancer	4.54e-05	0.000976	CbGpPWpGaD
Clonazepam—GABRG2—Neuronal System—RAF1—kidney cancer	4.52e-05	0.000972	CbGpPWpGaD
Clonazepam—GABRA3—Transmembrane transport of small molecules—ABCB1—kidney cancer	4.48e-05	0.000964	CbGpPWpGaD
Clonazepam—ALB—Hemostasis—GRB7—kidney cancer	4.47e-05	0.00096	CbGpPWpGaD
Clonazepam—ALB—Response to elevated platelet cytosolic Ca2+—VEGFA—kidney cancer	4.46e-05	0.000959	CbGpPWpGaD
Clonazepam—CYP2E1—Metabolism—CCBL1—kidney cancer	4.43e-05	0.000953	CbGpPWpGaD
Clonazepam—GABRB2—Transmission across Chemical Synapses—MAPK1—kidney cancer	4.43e-05	0.000952	CbGpPWpGaD
Clonazepam—GABRG2—Transmembrane transport of small molecules—ABCB1—kidney cancer	4.3e-05	0.000924	CbGpPWpGaD
Clonazepam—GABRA3—Transmission across Chemical Synapses—MAPK1—kidney cancer	4.22e-05	0.000908	CbGpPWpGaD
Clonazepam—ALB—Hemostasis—ITPR2—kidney cancer	4.15e-05	0.000893	CbGpPWpGaD
Clonazepam—ALB—Folate Metabolism—TP53—kidney cancer	4.13e-05	0.000888	CbGpPWpGaD
Clonazepam—CYP3A4—Phase 1 - Functionalization of compounds—POMC—kidney cancer	4.11e-05	0.000883	CbGpPWpGaD
Clonazepam—ALB—Metabolism of lipids and lipoproteins—CRABP1—kidney cancer	4.07e-05	0.000874	CbGpPWpGaD
Clonazepam—ALB—Metabolism—PDHB—kidney cancer	4.05e-05	0.000872	CbGpPWpGaD
Clonazepam—GABRG2—Transmission across Chemical Synapses—MAPK1—kidney cancer	4.05e-05	0.00087	CbGpPWpGaD
Clonazepam—GABRA1—Neuronal System—RAF1—kidney cancer	3.95e-05	0.00085	CbGpPWpGaD
Clonazepam—CYP2E1—Metabolism—PPAT—kidney cancer	3.85e-05	0.000827	CbGpPWpGaD
Clonazepam—CYP2E1—Metabolism—GLIPR1—kidney cancer	3.85e-05	0.000827	CbGpPWpGaD
Clonazepam—ALB—Metabolism—CCBL1—kidney cancer	3.81e-05	0.000819	CbGpPWpGaD
Clonazepam—NAT2—Metabolism—POMC—kidney cancer	3.79e-05	0.000816	CbGpPWpGaD
Clonazepam—GABRA1—Transmembrane transport of small molecules—ABCB1—kidney cancer	3.76e-05	0.000808	CbGpPWpGaD
Clonazepam—CYP2E1—Metabolism—APRT—kidney cancer	3.57e-05	0.000769	CbGpPWpGaD
Clonazepam—CYP2E1—Metabolism—FH—kidney cancer	3.57e-05	0.000769	CbGpPWpGaD
Clonazepam—GABRA1—Transmission across Chemical Synapses—MAPK1—kidney cancer	3.54e-05	0.000761	CbGpPWpGaD
Clonazepam—ALB—Metabolism of lipids and lipoproteins—ACHE—kidney cancer	3.45e-05	0.000741	CbGpPWpGaD
Clonazepam—GABRB2—Neuronal System—MAPK1—kidney cancer	3.39e-05	0.000729	CbGpPWpGaD
Clonazepam—CYP2E1—Metabolism—GPC3—kidney cancer	3.36e-05	0.000723	CbGpPWpGaD
Clonazepam—CYP3A4—Biological oxidations—GSTP1—kidney cancer	3.36e-05	0.000722	CbGpPWpGaD
Clonazepam—CYP3A4—Metapathway biotransformation—GSTP1—kidney cancer	3.31e-05	0.000712	CbGpPWpGaD
Clonazepam—ALB—Metabolism—PPAT—kidney cancer	3.3e-05	0.000711	CbGpPWpGaD
Clonazepam—ALB—Metabolism—GLIPR1—kidney cancer	3.3e-05	0.000711	CbGpPWpGaD
Clonazepam—CYP2E1—Metabolism—CA2—kidney cancer	3.27e-05	0.000703	CbGpPWpGaD
Clonazepam—ALB—Metabolism of lipids and lipoproteins—SCARB1—kidney cancer	3.26e-05	0.000702	CbGpPWpGaD
Clonazepam—GABRA3—Neuronal System—MAPK1—kidney cancer	3.24e-05	0.000696	CbGpPWpGaD
Clonazepam—ALB—Metabolism of lipids and lipoproteins—PTGS1—kidney cancer	3.23e-05	0.000694	CbGpPWpGaD
Clonazepam—CYP2E1—Metabolism—ALAD—kidney cancer	3.19e-05	0.000685	CbGpPWpGaD
Clonazepam—CYP2E1—Metabolism—ST3GAL2—kidney cancer	3.11e-05	0.000669	CbGpPWpGaD
Clonazepam—GABRG2—Neuronal System—MAPK1—kidney cancer	3.1e-05	0.000667	CbGpPWpGaD
Clonazepam—CYP3A4—Biological oxidations—GSTM1—kidney cancer	3.09e-05	0.000664	CbGpPWpGaD
Clonazepam—ALB—Metabolism—FH—kidney cancer	3.07e-05	0.000661	CbGpPWpGaD
Clonazepam—ALB—Metabolism—APRT—kidney cancer	3.07e-05	0.000661	CbGpPWpGaD
Clonazepam—ALB—Hemostasis—IFNA1—kidney cancer	3.05e-05	0.000655	CbGpPWpGaD
Clonazepam—CYP3A4—Metapathway biotransformation—GSTM1—kidney cancer	3.04e-05	0.000654	CbGpPWpGaD
Clonazepam—CYP2E1—Metabolism—ALDH1A1—kidney cancer	3.04e-05	0.000654	CbGpPWpGaD
Clonazepam—NAT2—Metabolism—PTGS2—kidney cancer	3.03e-05	0.000651	CbGpPWpGaD
Clonazepam—ALB—Metabolism of lipids and lipoproteins—BCHE—kidney cancer	3e-05	0.000646	CbGpPWpGaD
Clonazepam—CYP3A4—Biological oxidations—CYP1A1—kidney cancer	2.93e-05	0.000629	CbGpPWpGaD
Clonazepam—CYP2E1—Metabolism—PGK1—kidney cancer	2.91e-05	0.000627	CbGpPWpGaD
Clonazepam—CYP2E1—Metabolism—SLC5A3—kidney cancer	2.91e-05	0.000627	CbGpPWpGaD
Clonazepam—ALB—Metabolism—GPC3—kidney cancer	2.89e-05	0.000621	CbGpPWpGaD
Clonazepam—CYP3A4—Metapathway biotransformation—CYP1A1—kidney cancer	2.89e-05	0.00062	CbGpPWpGaD
Clonazepam—CYP2E1—Metabolism—LDHB—kidney cancer	2.86e-05	0.000614	CbGpPWpGaD
Clonazepam—ALB—Hemostasis—IFNA2—kidney cancer	2.84e-05	0.00061	CbGpPWpGaD
Clonazepam—ALB—Transmembrane transport of small molecules—SLC5A5—kidney cancer	2.82e-05	0.000606	CbGpPWpGaD
Clonazepam—ALB—Metabolism—CA2—kidney cancer	2.81e-05	0.000604	CbGpPWpGaD
Clonazepam—ALB—Metabolism—ALAD—kidney cancer	2.74e-05	0.000589	CbGpPWpGaD
Clonazepam—ALB—Platelet activation, signaling and aggregation—RAF1—kidney cancer	2.73e-05	0.000586	CbGpPWpGaD
Clonazepam—ALB—Transmembrane transport of small molecules—SLC2A1—kidney cancer	2.72e-05	0.000586	CbGpPWpGaD
Clonazepam—GABRA1—Neuronal System—MAPK1—kidney cancer	2.71e-05	0.000583	CbGpPWpGaD
Clonazepam—ALB—Metabolism—ST3GAL2—kidney cancer	2.67e-05	0.000575	CbGpPWpGaD
Clonazepam—GABRB2—Transmembrane transport of small molecules—RAF1—kidney cancer	2.66e-05	0.000572	CbGpPWpGaD
Clonazepam—NAT2—Metabolism—PTEN—kidney cancer	2.64e-05	0.000567	CbGpPWpGaD
Clonazepam—ALB—Metabolism—ALDH1A1—kidney cancer	2.61e-05	0.000562	CbGpPWpGaD
Clonazepam—CYP3A4—Metabolism—ACY1—kidney cancer	2.57e-05	0.000553	CbGpPWpGaD
Clonazepam—ALB—Hemostasis—IGF2—kidney cancer	2.55e-05	0.000549	CbGpPWpGaD
Clonazepam—GABRA3—Transmembrane transport of small molecules—RAF1—kidney cancer	2.54e-05	0.000545	CbGpPWpGaD
Clonazepam—ALB—Metabolism—PGK1—kidney cancer	2.5e-05	0.000538	CbGpPWpGaD
Clonazepam—ALB—Metabolism—SLC5A3—kidney cancer	2.5e-05	0.000538	CbGpPWpGaD
Clonazepam—CYP2E1—Metabolism—CA9—kidney cancer	2.48e-05	0.000533	CbGpPWpGaD
Clonazepam—ALB—Metabolism—LDHB—kidney cancer	2.46e-05	0.000528	CbGpPWpGaD
Clonazepam—ALB—Platelet activation, signaling and aggregation—IL2—kidney cancer	2.44e-05	0.000526	CbGpPWpGaD
Clonazepam—GABRG2—Transmembrane transport of small molecules—RAF1—kidney cancer	2.43e-05	0.000523	CbGpPWpGaD
Clonazepam—CYP3A4—Metabolism—PDHB—kidney cancer	2.19e-05	0.000471	CbGpPWpGaD
Clonazepam—CYP3A4—Biological oxidations—POMC—kidney cancer	2.18e-05	0.000469	CbGpPWpGaD
Clonazepam—ALB—Transmembrane transport of small molecules—ABCB1—kidney cancer	2.15e-05	0.000462	CbGpPWpGaD
Clonazepam—ALB—Metabolism—CA9—kidney cancer	2.13e-05	0.000458	CbGpPWpGaD
Clonazepam—GABRA1—Transmembrane transport of small molecules—RAF1—kidney cancer	2.13e-05	0.000457	CbGpPWpGaD
Clonazepam—CYP2E1—Metabolism—CRABP1—kidney cancer	2.11e-05	0.000453	CbGpPWpGaD
Clonazepam—ALB—Metabolism of lipids and lipoproteins—CYP1A1—kidney cancer	2.08e-05	0.000447	CbGpPWpGaD
Clonazepam—ALB—Platelet activation, signaling and aggregation—VEGFA—kidney cancer	2.08e-05	0.000447	CbGpPWpGaD
Clonazepam—CYP3A4—Metabolism—CCBL1—kidney cancer	2.06e-05	0.000442	CbGpPWpGaD
Clonazepam—ALB—Platelet activation, signaling and aggregation—MAPK3—kidney cancer	1.97e-05	0.000423	CbGpPWpGaD
Clonazepam—CYP2E1—Metabolism—ITPR2—kidney cancer	1.96e-05	0.000421	CbGpPWpGaD
Clonazepam—ALB—Platelet activation, signaling and aggregation—MAPK1—kidney cancer	1.87e-05	0.000402	CbGpPWpGaD
Clonazepam—NAT2—Metabolism—PIK3CA—kidney cancer	1.86e-05	0.0004	CbGpPWpGaD
Clonazepam—ALB—Metabolism—CRABP1—kidney cancer	1.81e-05	0.000389	CbGpPWpGaD
Clonazepam—CYP2E1—Metabolism—ACHE—kidney cancer	1.79e-05	0.000384	CbGpPWpGaD
Clonazepam—CYP2E1—Metabolism—GSTT1—kidney cancer	1.79e-05	0.000384	CbGpPWpGaD
Clonazepam—CYP3A4—Metabolism—PPAT—kidney cancer	1.78e-05	0.000384	CbGpPWpGaD
Clonazepam—CYP3A4—Metabolism—GLIPR1—kidney cancer	1.78e-05	0.000384	CbGpPWpGaD
Clonazepam—CYP2E1—Metabolism—SCARB1—kidney cancer	1.69e-05	0.000364	CbGpPWpGaD
Clonazepam—ALB—Metabolism—ITPR2—kidney cancer	1.68e-05	0.000362	CbGpPWpGaD
Clonazepam—CYP2E1—Metabolism—PTGS1—kidney cancer	1.67e-05	0.00036	CbGpPWpGaD
Clonazepam—CYP3A4—Metabolism—APRT—kidney cancer	1.66e-05	0.000357	CbGpPWpGaD
Clonazepam—CYP3A4—Metabolism—FH—kidney cancer	1.66e-05	0.000357	CbGpPWpGaD
Clonazepam—CYP2E1—Metabolism—PSMD7—kidney cancer	1.64e-05	0.000353	CbGpPWpGaD
Clonazepam—ALB—Platelet activation, signaling and aggregation—PIK3CA—kidney cancer	1.62e-05	0.000349	CbGpPWpGaD
Clonazepam—CYP3A4—Metabolism—GPC3—kidney cancer	1.56e-05	0.000335	CbGpPWpGaD
Clonazepam—CYP2E1—Metabolism—BCHE—kidney cancer	1.56e-05	0.000335	CbGpPWpGaD
Clonazepam—ALB—Metabolism of lipids and lipoproteins—POMC—kidney cancer	1.55e-05	0.000334	CbGpPWpGaD
Clonazepam—CYP2E1—Metabolism—SLC5A5—kidney cancer	1.54e-05	0.00033	CbGpPWpGaD
Clonazepam—ALB—Metabolism—ACHE—kidney cancer	1.54e-05	0.00033	CbGpPWpGaD
Clonazepam—ALB—Metabolism—GSTT1—kidney cancer	1.54e-05	0.00033	CbGpPWpGaD
Clonazepam—CYP3A4—Metabolism—CA2—kidney cancer	1.52e-05	0.000326	CbGpPWpGaD
Clonazepam—CYP2E1—Metabolism—SLC2A1—kidney cancer	1.48e-05	0.000319	CbGpPWpGaD
Clonazepam—CYP3A4—Metabolism—ALAD—kidney cancer	1.48e-05	0.000318	CbGpPWpGaD
Clonazepam—ALB—Metabolism—SCARB1—kidney cancer	1.45e-05	0.000312	CbGpPWpGaD
Clonazepam—CYP3A4—Metabolism—ST3GAL2—kidney cancer	1.44e-05	0.00031	CbGpPWpGaD
Clonazepam—ALB—Metabolism—PTGS1—kidney cancer	1.44e-05	0.000309	CbGpPWpGaD
Clonazepam—ALB—Metabolism—PSMD7—kidney cancer	1.41e-05	0.000303	CbGpPWpGaD
Clonazepam—CYP3A4—Metabolism—ALDH1A1—kidney cancer	1.41e-05	0.000303	CbGpPWpGaD
Clonazepam—ALB—Hemostasis—RAF1—kidney cancer	1.41e-05	0.000302	CbGpPWpGaD
Clonazepam—CYP3A4—Metabolism—PGK1—kidney cancer	1.35e-05	0.000291	CbGpPWpGaD
Clonazepam—CYP3A4—Metabolism—SLC5A3—kidney cancer	1.35e-05	0.000291	CbGpPWpGaD
Clonazepam—ALB—Metabolism—BCHE—kidney cancer	1.34e-05	0.000288	CbGpPWpGaD
Clonazepam—CYP3A4—Metabolism—LDHB—kidney cancer	1.33e-05	0.000285	CbGpPWpGaD
Clonazepam—ALB—Metabolism—SLC5A5—kidney cancer	1.32e-05	0.000284	CbGpPWpGaD
Clonazepam—ALB—Metabolism—SLC2A1—kidney cancer	1.28e-05	0.000274	CbGpPWpGaD
Clonazepam—ALB—Hemostasis—IL2—kidney cancer	1.26e-05	0.000271	CbGpPWpGaD
Clonazepam—CYP2E1—Metabolism—GSTP1—kidney cancer	1.24e-05	0.000266	CbGpPWpGaD
Clonazepam—ALB—Metabolism of lipids and lipoproteins—PTGS2—kidney cancer	1.24e-05	0.000266	CbGpPWpGaD
Clonazepam—ALB—Transmembrane transport of small molecules—RAF1—kidney cancer	1.22e-05	0.000262	CbGpPWpGaD
Clonazepam—CYP2E1—Metabolism—ABCB1—kidney cancer	1.17e-05	0.000252	CbGpPWpGaD
Clonazepam—CYP3A4—Metabolism—CA9—kidney cancer	1.15e-05	0.000247	CbGpPWpGaD
Clonazepam—CYP2E1—Metabolism—GSTM1—kidney cancer	1.14e-05	0.000245	CbGpPWpGaD
Clonazepam—ALB—Metabolism of lipids and lipoproteins—PTEN—kidney cancer	1.08e-05	0.000232	CbGpPWpGaD
Clonazepam—CYP2E1—Metabolism—CYP1A1—kidney cancer	1.08e-05	0.000232	CbGpPWpGaD
Clonazepam—ALB—Hemostasis—VEGFA—kidney cancer	1.07e-05	0.00023	CbGpPWpGaD
Clonazepam—ALB—Metabolism—GSTP1—kidney cancer	1.06e-05	0.000229	CbGpPWpGaD
Clonazepam—ALB—Hemostasis—MAPK3—kidney cancer	1.01e-05	0.000218	CbGpPWpGaD
Clonazepam—ALB—Metabolism—ABCB1—kidney cancer	1.01e-05	0.000217	CbGpPWpGaD
Clonazepam—ALB—Metabolism—GSTM1—kidney cancer	9.78e-06	0.00021	CbGpPWpGaD
Clonazepam—CYP3A4—Metabolism—CRABP1—kidney cancer	9.77e-06	0.00021	CbGpPWpGaD
Clonazepam—ALB—Hemostasis—MAPK1—kidney cancer	9.64e-06	0.000207	CbGpPWpGaD
Clonazepam—ALB—Metabolism—CYP1A1—kidney cancer	9.27e-06	0.000199	CbGpPWpGaD
Clonazepam—ALB—Hemostasis—KRAS—kidney cancer	9.1e-06	0.000196	CbGpPWpGaD
Clonazepam—CYP3A4—Metabolism—ITPR2—kidney cancer	9.09e-06	0.000195	CbGpPWpGaD
Clonazepam—ALB—Hemostasis—PIK3CA—kidney cancer	8.36e-06	0.00018	CbGpPWpGaD
Clonazepam—CYP3A4—Metabolism—ACHE—kidney cancer	8.29e-06	0.000178	CbGpPWpGaD
Clonazepam—CYP3A4—Metabolism—GSTT1—kidney cancer	8.29e-06	0.000178	CbGpPWpGaD
Clonazepam—ALB—Hemostasis—TP53—kidney cancer	8.09e-06	0.000174	CbGpPWpGaD
Clonazepam—CYP2E1—Metabolism—POMC—kidney cancer	8.04e-06	0.000173	CbGpPWpGaD
Clonazepam—CYP3A4—Metabolism—SCARB1—kidney cancer	7.84e-06	0.000169	CbGpPWpGaD
Clonazepam—CYP3A4—Metabolism—PTGS1—kidney cancer	7.76e-06	0.000167	CbGpPWpGaD
Clonazepam—ALB—Metabolism of lipids and lipoproteins—PIK3CA—kidney cancer	7.61e-06	0.000164	CbGpPWpGaD
Clonazepam—CYP3A4—Metabolism—PSMD7—kidney cancer	7.61e-06	0.000164	CbGpPWpGaD
Clonazepam—CYP3A4—Metabolism—BCHE—kidney cancer	7.22e-06	0.000155	CbGpPWpGaD
Clonazepam—CYP3A4—Metabolism—SLC5A5—kidney cancer	7.13e-06	0.000153	CbGpPWpGaD
Clonazepam—ALB—Metabolism—POMC—kidney cancer	6.91e-06	0.000149	CbGpPWpGaD
Clonazepam—CYP3A4—Metabolism—SLC2A1—kidney cancer	6.89e-06	0.000148	CbGpPWpGaD
Clonazepam—CYP2E1—Metabolism—PTGS2—kidney cancer	6.41e-06	0.000138	CbGpPWpGaD
Clonazepam—CYP3A4—Metabolism—GSTP1—kidney cancer	5.74e-06	0.000123	CbGpPWpGaD
Clonazepam—CYP2E1—Metabolism—PTEN—kidney cancer	5.59e-06	0.00012	CbGpPWpGaD
Clonazepam—ALB—Metabolism—PTGS2—kidney cancer	5.51e-06	0.000119	CbGpPWpGaD
Clonazepam—CYP3A4—Metabolism—ABCB1—kidney cancer	5.44e-06	0.000117	CbGpPWpGaD
Clonazepam—CYP3A4—Metabolism—GSTM1—kidney cancer	5.28e-06	0.000113	CbGpPWpGaD
Clonazepam—CYP3A4—Metabolism—CYP1A1—kidney cancer	5e-06	0.000108	CbGpPWpGaD
Clonazepam—ALB—Metabolism—PTEN—kidney cancer	4.81e-06	0.000103	CbGpPWpGaD
Clonazepam—CYP2E1—Metabolism—PIK3CA—kidney cancer	3.95e-06	8.48e-05	CbGpPWpGaD
Clonazepam—CYP3A4—Metabolism—POMC—kidney cancer	3.73e-06	8.02e-05	CbGpPWpGaD
Clonazepam—ALB—Metabolism—PIK3CA—kidney cancer	3.39e-06	7.29e-05	CbGpPWpGaD
Clonazepam—CYP3A4—Metabolism—PTGS2—kidney cancer	2.98e-06	6.4e-05	CbGpPWpGaD
Clonazepam—CYP3A4—Metabolism—PTEN—kidney cancer	2.6e-06	5.58e-05	CbGpPWpGaD
Clonazepam—CYP3A4—Metabolism—PIK3CA—kidney cancer	1.83e-06	3.94e-05	CbGpPWpGaD
